“Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s102. Accessed November 7, 2025. https://skin.dermsquared.com/skin/article/view/1079.